Design, Synthesis, and Biological Investigation of Thailanstatin A and Spliceostatin D Analogues Containing Tetrahydropyran, Tetrahydrooxazine, and Fluorinated Structural Motifs
K. C. Nicolaou, Santhosh Reddy Rekula, Sanjay Kumar, Ananda Rao Podilapu, Ryan P. Matuszak, Paul Jung, Lloyd T. Lam, Andrew C. Phillips, Joseph P. Lyssikatos, Stefan Munneke, Christine Gu, Hetal Sarvaiya, Joseph Sandoval, Mikhail Hammond, Monette Aujay, James W. Purcell, Regina M. Reilly, Julia Gavrilyuk
Abstract
Thailanstatin A and spliceostatin D, two naturally occurring molecules endowed with potent antitumor activities by virtue of their ability to bind and inhibit the function of the spliceosome, and their natural siblings and designed analogues, constitute an appealing family of compounds for further evaluation and optimization as potential drug candidates for cancer therapies. In this article, the design, synthesis, and biological investigation of a number of novel thailanstatin A analogues, including some accommodating 1,1-difluorocyclopropyl and tetrahydrooxazine structural motifs within their structures, are described. Important findings from these studies paving the way for further investigations include the identification of several highly potent compounds for advancement as payloads for antibody-drug conjugates (ADCs) as potential targeted cancer therapies and/or small molecule drugs, either alone or in combination with other anticancer agents.